增强器向的CRISPR激活拯救了发生了不够的自闭症易感基因
bioRxiv : the preprint server for biology
|April 1, 2024
概括
基因激活疗法显示出对自闭症谱系障碍 (ASD) 的治疗有希望. 这种方法针对增强剂来纠正基因哈普洛缺陷,为ASD和相关的神经发育障碍提供了潜在的新疗法.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 发展生物学 发展生物学
背景情况:
- 自闭症谱系障碍 (ASD) 是一种复杂的神经发育状况,具有重要的遗传基础.
- 新的突变,特别是那些导致基因哈普洛缺陷的突变,对ASD的遗传易感性有很大贡献.
结论:
- 针对基因激活的增强剂是ASD的可行的治疗策略.
- 这种方法有可能用于治疗其他的神经发育障碍,其特点是哈普洛缺陷.
更多相关视频
09:37Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
Published on: March 5, 2017
13.1K
11:36Rapid and Efficient Generation of Recombinant Human Pluripotent Stem Cells by Recombinase-mediated Cassette Exchange in the AAVS1 Locus
Published on: November 20, 2016
9.8K
相关概念视频
01:59CRISPR
50.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.8K
02:31Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K